Epsilon Healthcare Limited (HDRPF) Stock
Epsilon Healthcare Limited functions as a health and pharmaceuticals enterprise with core operations spanning Australia and Canada. The company's activities encompass the manufacturing and supply of hydroponic equipment, materials, and specialized nutrient solutions.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Epsilon Healthcare Limited
Epsilon Healthcare Limited functions as a health and pharmaceuticals enterprise with core operations spanning Australia and Canada. The company's activities encompass the manufacturing and supply of hydroponic equipment, materials, and specialized nutrient solutions. Furthermore, it focuses on the development and distribution of medicinal cannabis products, alongside providing comprehensive, turnkey cultivation systems for the plant. Established in 2016, the firm is headquartered in Sydney, Australia. Epsilon Healthcare Limited adopted its current identity in February 2021, having previously been known as THC Global Group Limited.
Epsilon Healthcare Limited is headquartered in AU.
Epsilon Healthcare Limited (HDRPF) stock trades at $0.01 with a market capitalization of $3.89M. The stock is valued at a price-to-earnings (P/E) ratio of -8.80, price-to-book of 4.37, price-to-sales of 0.69. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades at its 52-week high.
On profitability, Epsilon Healthcare Limited generates a return on equity (ROE) of -100.00%, return on capital employed of -16.87%, an operating margin of -18.04%, a net profit margin of -7.13%.
Official website: epsilonhealthcare.com.au